China Pharma Holdings CPHI
NYSE CPHI
$0.78 -0.06 (-7.30%)
As of: Sep 9, 2026 · 3:59 PM EDT

China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015)

China Pharma Holdings' (CPHI) quarterly Construction in Progress came in at $19747.0 in Q3 2015, down 99.84% on a YoY basis from $12.5 million in Q3 2014, and up 234.92% quarter-over-quarter from $5896.0 in Q2 2015.

Analysis

China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015) Analysis & Trends

China Pharma Holdings (CPHI) has reported Construction in Progress for 5 consecutive years, with $19747.0 the latest figure, recorded in Q3 2015.

  • For the quarter ending Q3 2015, Construction in Progress fell 99.84% year-over-year to $19747.0; the trailing twelve-month figure through Sep 2015 stood at $19747.0 (down 99.84% YoY), and the FY2014 full-year result was $5848.0, down 99.98% from the prior year.
  • Construction in Progress grew to $19747.0 in Q3 2015 per CPHI's latest filing, from $5896.0 in the prior quarter.
  • Across five years, Construction in Progress topped out at $29.7 million in Q2 2014 and bottomed at $5848.0 in Q4 2014.
  • Historically, Construction in Progress has averaged $8.8 million across 5 years, with a median of $3.7 million in 2012.
  • The sharpest annual moves came in 2013 and 2015: Construction in Progress soared 4227.86% in 2013, then sank 99.98% in 2015.
  • Over 5 years, Construction in Progress stood at $351571.0 in 2011, then soared by 949.17% to $3.7 million in 2012, then surged by 591.26% to $25.5 million in 2013, then slumped by 99.98% to $5848.0 in 2014, then jumped by 237.67% to $19747.0 in 2015.
  • According to Business Quant data, Construction in Progress over the past three periods registered $19747.0, $5896.0, and $5876.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 China Pharma Holdings 31.39 Mn 31.08 Mn 83,566.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 19,747.00
Jun 30, 2015 5,896.00
Mar 31, 2015 5,876.00
Dec 31, 2014 5,848.00
Sep 30, 2014 12.54 Mn
Jun 30, 2014 29.72 Mn
Mar 31, 2014 29.01 Mn
Dec 31, 2013 25.50 Mn
Sep 30, 2013 15.67 Mn
Jun 30, 2013 10.34 Mn
Mar 31, 2013 4.13 Mn
Dec 31, 2012 3.69 Mn
Sep 30, 2012 361,999.00
Jun 30, 2012 354,034.00
Dec 31, 2011 351,571.00